A. Soleiman
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Oncology top 10%
- Lymphatic System and Diseases
Papers in
-
- TGF-β signaling in diseases 1
- Protein Tyrosine Phosphatases 1
-
- Renal Diseases and Glomerulopathies 5
- Chronic Kidney Disease and Diabetes 1
- Co-authors
- Silvana Breiteneder-Geleff (2 shared papers)Dontscho Kerjaschki (2 shared papers)Romana Kalt (1 shared paper)K. Matsui (1 shared paper)G Schäffner (1 shared paper)Paul Meraner (1 shared paper)Ludwig Erlacher (5 shared papers)Klaus Bobacz (4 shared papers)
- Journals
- Nephrology Dialysis Transplantation (3 papers)European Journal of Clinical Investigation (3 papers)Clinical Nephrology (2 papers)Annals of the Rheumatic Diseases (1 paper)Osteoarthritis and Cartilage (1 paper)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
A. Soleiman
17 papers receiving 906 citations
Peers
Comparison fields: 5 of 75
- Nephrology 138
- Oncology 424
- Transplantation 33
- Rheumatology 133
- Genetics 76
Countries citing papers authored by A. Soleiman
This map shows the geographic impact of A. Soleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Soleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Soleiman more than expected).
Fields of papers citing papers by A. Soleiman
This network shows the impact of papers produced by A. Soleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Soleiman. The network helps show where A. Soleiman may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Soleiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. | 1997 | 421 |
| 2 | 2004 | 79 | |
| 3 | [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma]. | 1999 | 73 |
| 4 | 2003 | 71 | |
| 5 | 2002 | 60 | |
| 6 | 2009 | 52 | |
| 7 | 2003 | 43 | |
| 8 | 2009 | 24 | |
| 9 | 2011 | 23 | |
| 10 | 2007 | 17 | |
| 11 | 2012 | 16 | |
| 12 | 2006 | 11 | |
| 13 | 2008 | 9 | |
| 14 | 2004 | 8 | |
| 15 | 2001 | 7 | |
| 16 | 2007 | 4 | |
| 17 | 2003 | 1 | |
| 18 | 2024 | 0 | |
| 19 | 2024 | 0 |
About A. Soleiman
A. Soleiman is a scholar working on Molecular Biology, Nephrology, Rheumatology, Surgery and Oncology, having authored 19 papers that have together received 919 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Vasculitis and related conditions (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Chronic Kidney Disease and Diabetes (1 paper), Lymphatic System and Diseases (1 paper), TGF-β signaling in diseases (1 paper) and Protein Tyrosine Phosphatases (1 paper). The work is most often cited by research in Nephrology (138 citations), Oncology (424 citations), Transplantation (33 citations), Rheumatology (133 citations) and Genetics (76 citations). A. Soleiman has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Silvana Breiteneder-Geleff, Dontscho Kerjaschki, Romana Kalt, K. Matsui, G Schäffner, Paul Meraner, Ludwig Erlacher, Klaus Bobacz, W. Graninger and Reinhard Gruber. Their work appears in journals such as Nephrology Dialysis Transplantation, European Journal of Clinical Investigation, Clinical Nephrology, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.